Practical Considerations for Incorporating PrEP Into HIV Prevention Efforts in the Primary Care Setting
Douglas Krakower, MD
Assistant Professor of Medicine
Harvard Medical School
Division of Infectious Diseases
Beth Israel Deaconess Medical Center
The Fenway Institute, Fenway Health
Allison Gardner, PhD
Vice President, Educational Strategy and Content
Lisa R. Rinehart, MS, ELS
Director, Editorial Services
Kathryn Schaefer, MSN, RN
Lead Nurse Planner
Laura Muttini, RPh, MBA, CHCP
Chief Operating Officer
Jacksonville Beach, FL
Upon completion, participants should be able to:
- Identify strategies to establish open lines of communication with patients about their sexual history, behaviors, and goals in a culturally competent manner to better understand their HIV prevention needs
- Incorporate PrEP services into prevention options for patients who have a substantial risk of HIV
This activity is intended for primary care clinicians, including physicians and nurse practitioners.
Series Overview/Statement of Need
Pre-exposure prophylaxis (PrEP) is a relatively new addition to the available arsenal of structural, biomedical, and behavioral strategies designed to prevent ongoing HIV transmission. Mounting data in real-world treatment settings across the United States are confirming the results observed in landmark clinical trials that PrEP, when used consistently, is a safe and effective prevention approach for individuals who have a substantial risk of HIV. However, with the exception of major urban areas with high populations of early adopters of this strategy, PrEP remains largely underused nationwide. Surveys indicate that an awareness of and knowledge about PrEP remains suboptimal among primary care clinicians. Therefore, educational interventions to increase clinicians’ understanding about the benefits, limitations, and practical implementation of PrEP for HIV prevention are needed.
Provided by Med-IQ. Powered by ProDoctor.
Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Med-IQ designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses, nurse practitioners, physician assistants, and other healthcare professionals who successfully complete the activity will receive a Statement of Participation indicating the maximum credits available.
Medium/Method of Participation
This CME activity consists of a 1.0-credit case simulation. To receive credit, read the introductory CME material, review the case simulation complete the post-survey, evaluation, attestation, and post-test, answering at least 70% of the post-test questions correctly.
Initial Release Date: October 25, 2017
Expiration Date: October 24, 2018
Estimated Time to Complete This Activity: 1 hour
Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.
The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation.
Laura Muttini, RPh, MBA, CHCP
Ownership interest (stocks/stock options – excluding mutual funds): Abbott Laboratories, AbbVie Inc.
Douglas Krakower, MD, has indicated no real or apparent conflicts.
The writer, peer reviewers, and other activity planners have no financial relationships to disclose.
Statement of Evidence-Based Content
Educational activities that assist physicians in carrying out their professional responsibilities more effectively and efficiently are consistent with the ACCME definition of continuing medical education (CME). As an ACCME-accredited provider of CME, it is the policy of Med-IQ to review and ensure that all the content and any recommendations, treatments, and manners of practicing medicine in CME activities are scientifically based, valid, and relevant to the practice of medicine. Med-IQ is responsible for validating the content of the CME activities it provides. Specifically, (1) all recommendations addressing the medical care of patients must be based on evidence that is scientifically sound and recognized as such within the profession; (2) all scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection, and analysis.
Med-IQ is not liable for any decision made or action taken in reliance upon the information provided through this activity.
For questions or comments about this activity, please contact Med-IQ.
Call (toll-free) 866 858 7434 or e-mail email@example.com.
Microsoft Windows® 8, Windows 7
Mac OS 10.7 (Lion) or newer
Microsoft Internet Explorer 8.0 or later
Mozilla Firefox - latest version
Google Chrome - latest version
Apple Safari - latest version
Adobe Acrobat Reader® or Adobe Reader
Adobe Flash Player
Adobe Flash Player 9 or later
For technical support, go to http://www.med-iq.com/index.cfm?fuseaction=content.support
Med-IQ fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please contact Med-IQ at 443 543 5200.
The information provided through this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.
Privacy & Confidentiality
Med-IQ is committed to honoring your privacy and protecting any personal information you choose to share with us. For detailed information about our privacy notice, please visit: www.med-iq.com/privacy-statement/.
Acknowledgment of Commercial Support
This activity is supported by an educational grant from Gilead Sciences, Inc.
© Med-IQ, LLC
The following material has been developed to accompany this activity:
Note: This material is not accredited for CME and, therefore, does not offer any CME/CE credit.
Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.